TEVA PHARMACEUTICAL INDUSTRIES LTD
Congressional Trades
Whale Activity
- Increased5
- New310
- Held8
- Decreased9
- Closed372
- No prior filing271
| Filer | Shares | Value | Change |
|---|---|---|---|
| BANK OF MONTREAL /CAN/ | 1.1M | $4.53B | new |
| BlackRock, Inc. | 63.4M | $2.51B | — |
| Phoenix Financial Ltd. | 42.6M | $1.69B | new |
| WCM INVESTMENT MANAGEMENT, LLC | 42.3M | $1.68B | — |
| Harel Insurance Investments & Financial Services Ltd. | 34.7M | $1.37B | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 32.5M | $1.29B | — |
| FMR LLC | 25.8M | $1.02B | — |
| STATE STREET CORP | 19.3M | $764.6M | — |
| Capital World Investors | 18.0M | $713.1M | — |
| Lingotto Investment Management LLP | 17.5M | $694.4M | new |
| GEODE CAPITAL MANAGEMENT, LLC | 11.9M | $470.4M | new |
| Rubric Capital Management LP | 11.6M | $458.4M | — |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Sabag MarkSee "Remarks" | Sale | −44.7K | $44.14 | $2.0M | Nov 12, 2026 | Form 4 ↗ |
| Daniell RichardEVP, Europe Commercial | Sale | −20.0K | $42.80 | $856K | Nov 11, 2026 | Form 4 ↗ |
| Francis Richard DPresident and CEO | Sale | −250.0K | $42.24 | $10.6M | Nov 10, 2026 | Form 4 ↗ |
| Daniell RichardEVP, Europe Commercial | Sale | −25.0K | $42.91 | $1.1M | Nov 9, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −9,534 | $43.03 | $410K | Nov 9, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −7,093 | $43.03 | $305K | Nov 9, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −662 | $43.15 | $29K | Nov 9, 2026 | Form 4 ↗ |
| Sabag MarkSee "Remarks" | Sale | −46.0K | $41.93 | $1.9M | Nov 5, 2026 | Form 4 ↗ |
| Bergwerk DovInterim Cheif Legal Officer | Sale | −8,755 | $41.72 | $365K | Nov 4, 2026 | Form 4 ↗ |
| Bergwerk DovInterim Cheif Legal Officer | Sale | −17.5K | $41.72 | $730K | Nov 4, 2026 | Form 4 ↗ |
| Savage BrianInterim Chief Legal Officer | Sale | −314 | $38.70 | $12K | Sep 18, 2026 | Form 4 ↗ |
| Savage BrianInterim Chief Legal Officer | Sale | −2,525 | $39.15 | $99K | Sep 18, 2026 | Form 4 ↗ |
| Savage BrianInterim Chief Legal Officer | Sale | −4,503 | $38.69 | $174K | Sep 18, 2026 | Form 4 ↗ |
| Savage BrianInterim Chief Legal Officer | Option exercise | +4,503 | $34.70 | $156K | Sep 18, 2026 | Form 4 ↗ |
| MIGNONE ROBERTODirector | Sale | −367.6K | $39.06 | $14.4M | Sep 18, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −2,500 | $37.63 | $94K | Aug 21, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Option exercise | +2,500 | $19.61 | $49K | Aug 21, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −6,945 | $37.61 | $261K | Aug 21, 2026 | Form 4 ↗ |
| Satchi-Fainaro RonitDirector | Sale | −415 | $37.25 | $15K | Aug 21, 2026 | Form 4 ↗ |
| Lippman EvanEVP, Business Development | Sale | −18.6K | $36.57 | $680K | Aug 17, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 17.1M | $607.8M | 0.09% | Jul 31, 2026 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 11.3M | $382.6M | 0.12% | Jun 30, 2026 |
| VANGUARD FTSE ALL-WORLD EX-US INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 2.8M | $98.4M | 0.10% | Jul 31, 2026 |
| SOUND SHORE FUND SOUND SHORE FUND, INC. | 1.2M | $46.5M | 4.87% | Sep 30, 2026 |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 984.9K | $35.0M | 0.04% | Jul 31, 2026 |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 237.1K | $8.5M | 0.12% | Aug 31, 2026 |
| Empower International Index Fund EMPOWER FUNDS, INC. | 187.2K | $7.4M | 0.21% | Sep 30, 2026 |
| Empower International Value Fund EMPOWER FUNDS, INC. | 71.1K | $2.8M | 0.18% | Sep 30, 2026 |
| Empower Core Strategies: International Equity Fund EMPOWER FUNDS, INC. | 43.6K | $1.7M | 0.14% | Sep 30, 2026 |
| Invesco International Developed Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 17.6K | $632K | 0.06% | Aug 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list TEVA's shares (CUSIP M8769Q102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Corporate Lobbying
No lobbying filings found naming TEVA PHARMACEUTICAL INDUSTRIES LTD as the client.
Government Contracts
No federal contract awards found for TEVA PHARMACEUTICAL INDUSTRIES LTD.
U.S. Patents
No USPTO patent applications found for TEVA PHARMACEUTICAL INDUSTRIES LTD.
Annual Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $17.26B | $16.54B | $15.85B | $14.93B | $15.88B |
| Operating income | $2.16B | -$303.0M | $433.0M | -$2.20B | $1.72B |
| Net income | $1.41B | -$1.64B | -$559.0M | -$2.45B | $417.0M |
| Diluted EPS | $1.21 | -$1.45 | -$0.50 | -$2.20 | $0.38 |
| Operating cash flow | $1.65B | $1.25B | $1.37B | $1.59B | $798.0M |
| Cash and equivalents | $3.56B | $3.30B | $3.23B | $2.80B | $2.17B |
| Total assets | $40.75B | $39.33B | $43.48B | $44.01B | $47.67B |
| Total liabilities | $32.83B | $33.61B | $35.35B | $35.41B | $36.42B |
| Shareholders' equity | $7.91B | $5.37B | $7.51B | $7.80B | $10.28B |
As TEVA PHARMACEUTICAL INDUSTRIES LTD tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 3, 2026 ↗
Stock Splits
- 2-for-1Stock splitJul 1, 2004
- 2-for-1Stock splitDec 6, 2002
- 2-for-1Stock splitFeb 23, 2000
- 2-for-1Stock splitApr 14, 1993
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
- 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureNov 18, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsNov 3, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeOct 29, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationSep 16, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsSep 14, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsSep 11, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 3, 2026
EDGAR ↗ - 8-K · Items 3.03, 9.01Modification of rightsSep 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 29, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 28, 2026
EDGAR ↗













